India has banned the export of Tapentadol, Carisoprodol combination drugs to certain West African nations amid report of ...
The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.
FDA feedback confirms Adial's proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging ...
Health care providers can now administer Sublocade subcutaneously into the thigh, buttock, or the back of the upper arm, in addition to the abdomen.
Indian authorities banned the manufacturing and export of Tapentadol, Carisoprodol combination drugs, two highly addictive ...
FDA officials have identified nine more companies allowed to manufacture and export a banned, lethal drug combination linked ...
The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...
The case emerged following an investigative report by BBC, which uncovered the sale of Aveo-branded combination medicines in ...
Opinion
Opioid warning
India’s weak drug regulation is spreading a problem from Africa to America. Reputational damage can be big India’s drug regulators have been caught napping once again. Various pills made by ...
Africa, Bright Simons, has provided a detailed breakdown of the opioid crisis uncovered in the latest BBC Africa Eye ...
In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...
Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.